v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net (loss) income $ (12,388) $ 6,724
Adjustments to reconcile net (loss) income to net cash flows from operating activities:    
Depreciation and amortization 40,735 46,784
Stock-based compensation expense 10,997 8,978
Deferred tax (benefit) expense (6,402) 29
Gain on sale of assets, net (9,834) (316)
Loss on divestiture 2,072 0
Changes in working capital items (43,362) (35,609)
Decrease in other non-current assets 10,614 11,724
Decrease in other non-current liabilities (12,371) (7,782)
Other operating activities, net 1,258 (691)
Net cash (used in) provided by operating activities (18,681) 29,841
Cash flows from investing activities:    
Capital expenditures (18,271) (24,033)
Acquisitions, net of cash acquired (2,218) (5,825)
Proceeds from sale of assets 14,608 376
Proceeds from divestiture 2,049 0
Other investing activities, net (63) (281)
Net cash used in investing activities (3,895) (29,763)
Cash flows from financing activities:    
Proceeds from long-term debt 495,634 491,142
Payments on long-term debt (445,416) (449,509)
Purchases of treasury stock (4,426) (17,220)
Dividends (17,047) (16,691)
Proceeds from net investment hedge 14,990 0
Acquisition holdback and deferred purchase price payments (10,184) 0
Payments of debt issuance costs 0 (4,704)
Net cash provided by financing activities 33,551 3,018
Effect of exchange rate changes on cash (1,545) 300
Net change in cash and cash equivalents including balances classified as assets held-for-sale 9,430 3,396
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Held For Sale (10,000) 0
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Net of Held For Sale Assets (570) 3,396
Cash and cash equivalents at beginning of year 40,816 42,101
Cash and cash equivalents at end of period $ 40,246 $ 45,497